pharmacogenomic test

pharmacogenomic test

An assay intended to study interindividual variations in candidate genes, biomarkers, and in gene expression or inactivation, which correlate with pharmacologic activity and therapeutic responses.
References in periodicals archive ?
II-69 Illumina to Launch VeriSeq Embryo Screening Tool II-69 GENEWIZ Launches PGxOne(TM) Pharmacogenomic Test II-69 Ambry Genetics Launches ExomeNext(TM) and ExomeNext-Rapid(TM) Genetic Tests.
a company that provides a pharmacogenomic test, said in an interview.
deCODE recently signed an agreement with Genmab A/S to develop a pharmacogenomic test for a novel treatment for rheuma-toid arthritis.
According to the document, a pharmacogenomic test may be considered a valid biomarker if "it is measured in an analytical test system with well-established performance characteristics" and "there is an established scientific framework or body of evidence that elucidates the physiologic, pharmacologic, toxicologic, or clinical signification of the test result.
GeneSight is the only neuropsychiatric pharmacogenomic test available that is based on proprietary and patented combinatorial technology.
As defined by the document, pharmacogenomics is "the use of a pharmacogenomic or pharmacogenomic test in conjunction with drug therapy.
Assurex Health today announced that Medicare has issued a Local Coverage Determination (LCD) that will provide coverage for GeneSight Psychotropic, the first combinatorial pharmacogenomic test to help guide medication decisions for depression.
GeneSight is a laboratory developed pharmacogenomic test that uses cutting edge technology to measure and analyze clinically important genomic variants in the treatment of neuropsychiatric disorders.
Notably, GeneSight Psychotropic is the first and only psychiatric pharmacogenomic test to offer CYP3A4 analysis distinct and separate from CYP3A5.
5, 2013 /PRNewswire/ -- Assurex Health, a leading personalized medicine company, announced today the publication of a third clinical study providing evidence for the effectiveness of the GeneSight combinatorial pharmacogenomic test over the current method for selecting psychotropic medications.
About GeneSight GeneSight is a laboratory-developed pharmacogenomic test that uses cutting edge technology to measure and analyze clinically important genomic variants in the treatment of psychiatric disorders.
MTHFR, the latest addition to its pharmacogenomic test panel.